ELOXX PHARMACEUTICALS, INC. Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge of -$512.10 thousand for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-14.
Discontinued › Income Statement › Other Income
us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1 · last filed 2017-11-14
- ELOXX PHARMACEUTICALS, INC. change in unrealized gain (loss) on hedged item in fair value hedge for the quarter ending 2017-09-30 was -$512.10K.
- ELOXX PHARMACEUTICALS, INC. change in unrealized gain (loss) on hedged item in fair value hedge for the quarter ending 2017-06-30 was -$55.55K.
- ELOXX PHARMACEUTICALS, INC. change in unrealized gain (loss) on hedged item in fair value hedge for the quarter ending 2017-03-31 was $55.55K.
- ELOXX PHARMACEUTICALS, INC. change in unrealized gain (loss) on hedged item in fair value hedge for the quarter ending 2016-03-31 was $0.00.
| Period end | Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge 1 month | Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge 3 month | Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge 6 month | Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge 9 month | Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge 12 month | Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge 12 month as first filed |
|---|---|---|---|---|---|---|
| 2017-09-30 | -$512.10K 10-Q · filed 2017-11-14 | -$567.65K derived: sum of 2 quarters · filed 2017-11-14 | -$512.10K derived: sum of 3 quarters · filed 2017-11-14 | |||
| 2017-07-28 | $512.10K 10-Q · filed 2017-11-14 | |||||
| 2017-06-30 | -$55.55K derived: 10-Q 12 month − 10-Q 9 month · filed 2017-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-11-14 | $0.00 10-Q · filed 2017-11-14 | -$1.18M 10-K · filed 2017-10-13 | ||
| 2017-03-31 | $55.55K 10-Q · filed 2017-05-22 | $55.55K 10-Q · filed 2017-05-22 | ||||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-22 | $0.00 10-Q · filed 2017-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |